Silvestro Stephen L
SEC CIK 1773461 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Chief Commercial Off | 183.6K | $50.1K | $5.23M | 44 | 2021-07-20 | 2026-08-21 |
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 16:58 | 2026-08-20 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | A - Grant | $0.00 | +79.2K | 262.8K | +43% | $0 | |
| 2026-08-24 15:14 | 2026-08-21 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | F - Tax | $7.71 | -1,737 | 183.6K | -0.9% | -$13.4K | |
| 2026-05-18 16:43 | 2026-05-15 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | F - Tax | $5.21 | -5,219 | 185.3K | -3% | -$27.2K | |
| 2025-12-23 | 2025-12-23 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | F - Tax | $12.74 | -3,361 | 190.5K | -2% | -$42.8K | |
| A | 2025-12-23 | 2025-12-23 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | F - Tax | $12.74 | -3,361 | 190.5K | -2% | -$42.8K |
| D | 2025-12-22 | 2025-12-19 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | M - OptEx | $0.00 | +6,546 | 195.5K | +3% | $0 |
| D | 2025-12-22 | 2025-12-19 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | F - Tax | $13.51 | -1,594 | 193.9K | -0.8% | -$21.5K |
| D | 2025-10-07 | 2025-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | S - Sale+OE | $18.75 | -1,620 | 188.9K | -0.9% | -$30.4K |
| D | 2025-10-07 | 2025-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | M - OptEx | $0.00 | +6,649 | 190.5K | +4% | $0 |
| D | 2025-08-25 | 2025-08-21 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CEO | A - Grant | $0.00 | +15.6K | 183.9K | +9% | $0 |
| D | 2025-05-19 | 2025-05-15 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | A - Grant | $0.00 | +46.9K | 168.3K | +39% | $0 |
| D | 2025-03-04 | 2025-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,928 | 121.9K | +2% | $0 |
| D | 2025-03-04 | 2025-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $5.18 | -572 | 121.3K | -0.5% | -$2,963 |
| 2025-02-20 | 2025-02-15 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $6.64 | -2,298 | 120.0K | -2% | -$15.3K | |
| D | 2024-12-27 | 2024-12-23 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | A - Grant | $0.00 | +41.4K | 122.3K | +51% | $0 |
| D | 2024-12-20 | 2024-12-19 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $4.75 | -2,576 | 80.8K | -3% | -$12.2K |
| D | 2024-12-20 | 2024-12-19 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +6,546 | 83.4K | +9% | $0 |
| D | 2024-10-07 | 2024-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $7.83 | -2,617 | 76.9K | -3% | -$20.5K |
| D | 2024-10-07 | 2024-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +6,649 | 79.5K | +9% | $0 |
| A | 2024-05-06 | 2024-02-15 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | A - Grant | $0.00 | +7,750 | 16.9K | +85% | $0 |
| D | 2024-05-06 | 2024-05-02 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $10.70 | -35.4K | 72.8K | -33% | -$378.9K |
| D | 2024-05-06 | 2024-05-02 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +90.0K | 108.3K | +493% | $0 |
| A | 2024-05-06 | 2024-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $15.95 | -572 | 18.3K | -3% | -$9,123 |
| A | 2024-05-06 | 2024-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,927 | 18.8K | +11% | $0 |
| 2024-04-24 | 2024-03-15 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | A - Grant | $0.00 | +7,750 | 13.7K | +130% | $0 | |
| D | 2024-03-06 | 2024-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $15.95 | -668 | 5,956 | -10% | -$10.7K |
| D | 2024-03-06 | 2024-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,927 | 6,624 | +41% | $0 |
| D | 2023-10-06 | 2023-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $7.06 | -1,952 | 4,697 | -29% | -$13.8K |
| D | 2023-10-06 | 2023-10-03 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +6,649 | 6,649 | New | $0 |
| D | 2023-03-03 | 2023-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | F - Tax | $18.11 | -668 | 4,459 | -13% | -$12.1K |
| D | 2023-03-03 | 2023-03-01 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,927 | 5,127 | +60% | $0 |
| 2022-08-17 | 2022-08-16 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CCO | P - Purchase | $15.66 | +3,200 | 3,200 | New | +$50.1K | |
| D | 2021-12-21 | 2021-12-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $54.87 | -13.2K | 0 | -100% | -$726.5K |
| D | 2021-12-21 | 2021-12-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-11-19 | 2021-11-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-11-19 | 2021-11-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $73.98 | -13.2K | 0 | -100% | -$979.6K |
| D | 2021-10-19 | 2021-10-18 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-10-19 | 2021-10-18 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $85.38 | -13.2K | 0 | -100% | -$1.13M |
| D | 2021-09-21 | 2021-09-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CCO | S - Sale+OE | $69.79 | -13.2K | 0 | -100% | -$924.2K |
| D | 2021-09-21 | 2021-09-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CCO | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-08-19 | 2021-08-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-08-19 | 2021-08-17 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $58.41 | -13.2K | 0 | -100% | -$773.5K |
| D | 2021-07-21 | 2021-07-20 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $50.34 | -13.2K | 0 | -100% | -$666.6K |
| D | 2021-07-21 | 2021-07-20 | OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
Purchase Sale Sale after option exercise All abbreviations